WAYNE REMELL WALKER

CIK 1428761 · last filed 2026-09-23

WAYNE REMELL WALKER is a corporate insider who has filed 56 SEC Form 4 insider transactions across 10 companies since 2020. The most recent filing, for PBI, was dated Sep 23, 2026. Across all open-market trades the lifetime net is −$36.4K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $5.0M across reported positions. 6 SEC filings were submitted jointly with PharmaCyte Biotech, Inc.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$5.02M

Companies

10

Total Filings

56

Lifetime Open-Market Net

-$36.4K

Filer Profile

Reported Address
1515 MARKET STREET
SUITE 1720
PHILADELPHIA, PA 19103
Related Filers
PharmaCyte Biotech, Inc. — 6 joint filings, latest 2026-07-17
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
PBI Director 5,601 $16.38 $91.7K $0 3 2026-09-23
POWW Director 191,413 $2.29 $438.3K $0 1 2026-08-19
PMCB Director 20,625 $0.44 $9.1K $0 5 2026-07-17
FABC Director — $2.41 — $0 1 2026-06-18
POWWP Director 176,413 $24.30 $4.29M $0 14 2026-05-19
StableX Technologies, Inc. (SBLX) Delisted Director — $3.10 — $0 1 2025-10-31
Petros Pharmaceuticals, Inc. (PTPI) Delisted Director 6,333 $0.01 $39 $0 8 2025-02-21
StableX Technologies, Inc. (AYRO) Delisted Director 6,362 $7.08 $45.0K -$36.4K 10 2024-12-02
WRAP Director 134,575 $1.45 $195.1K $0 6 2023-10-19
WRAP TECHNOLOGIES, INC. (WRTC) Delisted Director 10,070 — — $0 1 2020-01-17

Recent Filings

56 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-09-23 PBI Exer (M) +5,601 $0 EDGAR
2026-08-19 POWW Grant (A) +15,000 $0 EDGAR
2026-07-17 PMCB Other (J) — $0 EDGAR
2026-06-18 FABC Grant (A) — $0 EDGAR
2026-06-08 — Grant (A) +375,000 $0
2026-05-19 POWWP Grant (A) +15,000 $29.1K EDGAR
2026-05-14 PBI Grant (A) — $0 EDGAR
2026-04-02 PMCB Grant (A) — $0 EDGAR
2026-02-18 POWWP Grant (A) +15,000 $0 EDGAR
2026-01-02 — Grant (A) +500,000 $0
Showing 1–10 of 56
Page 1 of 6
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.